You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in South Korea

Sep 2011

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in South Korea with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in South Korea, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in South Korea for free:

The Consumer Health in South Korea market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in South Korea?
  • What are the major brands in South Korea?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health shows healthy growth in 2010

Consumer health showed strong growth of 13% in value terms in South Korea during 2010, mainly thanks to the good performance of vitamins and dietary supplements and weight management. With the continued concern about health and wellness, many South Korean consumers are taking vitamins and dietary supplements to boost their general health and to look younger. The “trying to look younger” trend continued in 2010, with weight management and vitamins and dietary supplements claiming to improve skin health continuing to see strong growth in this year. In the case of OTC products, South Korean consumers still prefer to consult doctors rather than self-medicate. However, the South Korean government has expanded the product range for dereimbursement to boost the public health insurance budget deficit, which helped OTC to show marginal growth in 2010.

More South Korean consumers suffer from environmental pollution

Environmental pollution-related problems such as rhinitis, asthma and atopic skin have increased a lot, especially among children, who have a relatively weaker immune system than adults, in South Korea. According to the National Health Insurance Corporation, there are about eight million patients suffering from rhinitis, asthma and atopic skin in South Korea. As the number of these patients rapidly increases, related remedies also grew in 2010. Every spring in particular many South Korean consumers suffer from yellow sand from China, which is known to contain heavy metals that can cause various health issues. Manufacturers introduced various consumer health and nutritional products to treat environmental pollution-related diseases during the review period.

Selected pharmacies allowed to operate 24 hours a day

The South Korean government has been working on the expansion of distribution channels for some consumer health products that are commonly used by South Korean consumers, including analgesics and digestive remedies. However, this new policy to extend OTC distribution to grocery retailers was delayed again in 2010. Instead, the Korea Pharmaceutical Association suggested 24-hour opening for selected pharmacies around the country to offer more convenience to South Korean consumers and help satisfy increasing demand.

Distribution channels for vitamins and dietary supplements become more diverse

The distributional channels for nutritionals have been diversified. Vitamins, dietary supplements and weight management were mainly distributed through direct selling. However, recently, with young consumers of nutritionals increasing, they tend to prefer store-based channels, internet retailing or homeshopping, and this has diversified the distributional channels for nutritionals. Nevertheless, specific product information provided by professional salespersons is still important even to young consumers. Manufacturers are expanding channels to cover consumers of all ages at the same time as offering professional salespersons.

Consumer health expected to post marginal growth over the forecast period

Consumer health is expected to gradually increase in the future based on strong growth rates in nutritionals such as vitamins, dietary supplements and weight management products. As new “individually approved” dietary supplements are constantly launched, consumers’ tastes will change quickly. Even though popular products will fluctuate, the overall market size will continue to grow. On the other hand, the consumer health market will show a negative growth rate over the forecast period.

Table of Contents

Table of Contents

Consumer Health in South Korea - Industry Overview

EXECUTIVE SUMMARY

Consumer health shows healthy growth in 2010

More South Korean consumers suffer from environmental pollution

Selected pharmacies allowed to operate 24 hours a day

Distribution channels for vitamins and dietary supplements become more diverse

Consumer health expected to post marginal growth over the forecast period

KEY TRENDS AND DEVELOPMENTS

Consumer health shows a healthy growth rate in 2010

Expansion of retail distribution channels for consumer health still in dispute

Treatment for disease caused by pollution shows a good performance

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/Self-care and Preventive Medicine

Switches

DEFINITIONS

Sources

  • Summary 1 Research Sources

Consumer Health in South Korea - Company Profiles

Daewoong Pharmaceutical Co Ltd in Consumer Health (South Korea)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 4 Daewoong Pharmaceutical Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 5 Daewoong Pharmaceutical Co Ltd: Competitive Position 2010

Dong Wha Pharmaceutical Industrial Co Ltd in Consumer Health (South Korea)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 8 Dong Wha Pharmaceutical Industrial Co Ltd: Production Statistics

COMPETITIVE POSITIONING

  • Summary 9 Dong Wha Pharmaceutical Industrial Co Ltd: Competitive Position 2010

Dong-A Pharmaceutical Co Ltd in Consumer Health (South Korea)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 12 Dong-A Pharmaceutical Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 13 Dong-A Pharmaceutical Co Ltd: Competitive Position 2010

Korea Ginseng Corp in Consumer Health (South Korea)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 16 Korea Ginseng Corp: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 17 Korea Ginseng Corp: Competitive Position 2010

Kwang Dong Pharm Co Ltd in Consumer Health (South Korea)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 20 Kwang Dong Pharm Co Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 21 Kwang Dong Pharm Co Ltd: Competitive Position 2010

Adult Mouth Care in South Korea - Category Analysis

HEADLINES

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 14 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in South Korea - Category Analysis

HEADLINES

TRENDS

  • Safety concerns over IPA continued until 2010, although the Korea Food and Drug Administration (KFDA) decided to limit its usage for children under 15 years of age in 2009. Most companies introduced renewal-related products and launched new analgesics without IPA ingredients, although products including IPA still remained available on the market. Now, doctors are insisting those analgesics containing IPA should be switched to Rx as they can cause serious side-effects, but the KFDA has maintained its previous opinion that there is no specific and clear research proving IPA causes harm to health.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sam Jin Pharm Co Ltd maintained the leading position in systemic analgesics in South Korea in 2010 with a 20% share of value sales, although its sales decreased by 11% from 2009. Safety concerns surrounding the ingredient IPA in analgesics were still a hot topic in South Korea, so other companies launched renewed products without IPA, although Geworin containing IPA was still being distributed through chemists/pharmacies. As a result, its value share decreased in both 2009 and 2010.

PROSPECTS

  • Analgesics is expected to record a CAGR of -1% in constant value terms over the forecast period to stand at Won115 billion in 2015. While acetaminophen will maintain a positive growth rate, but only fractionally (i.e. with a CAGR of well under 1%), aspirin will show a strong growth rate (3% CAGR) based on demand for 100mg aspirin as a high blood pressure remedy.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 20 Analgesics Company Shares by Value 2006-2010
  • Table 21 Analgesics Brand Shares by Value 2007-2010
  • Table 22 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in South Korea - Category Analysis

HEADLINES

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2005-2010
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 26 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 27 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in South Korea - Category Analysis

HEADLINES

TRENDS

  • With H1N1 spreading rapidly through South Korea in 2009, most consumers consulted doctors as soon as they detected any flu-like symptoms, which negatively affected the performance of OTC cough, cold and allergy remedies products in South Korea. However, after the initial impact of H1N1, people realised they should always try and take care of their own health by themselves, so cough, cold and allergy OTC products as household medicines recorded a temporary spike in sales in late 2009.

SWITCHES

COMPETITIVE LANDSCAPE

  • Kwang Dong Pharm Co Ltd lost its leading position as its share slipped below 15% due to the excess artificial preservatives scandal in 2010. Although the company experienced a serious scandal, it immediately launched products with non-artificial preservatives, and also recalled all existing products, therefore limiting the impact of the scandal.

PROSPECTS

  • Cough, cold and allergy remedies is expected to post a negative CAGR of almost -2% in constant value terms between 2010 and 2015 as more consumers prefer to consult doctors and manufacturers are less keen to introduce new products. Decongestants is expected to be one of the worst performers with a negative CAGR of -5% as sales fall to less than Won5 billion in 2015 from more than Won6 billion in 2010.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 32 Sales of Decongestants by Category: Value 2005-2010
  • Table 33 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 34 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in South Korea - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies continued to see negative growth in 2010 with current value sales falling 1% as consumers preferred consultations with a doctor when experiencing digestive disorders. In addition, with increasing use of dietary supplements that can help digest, these OTC products were replaced by dietary supplements. Motion sickness also showed a strong decline in 2010 with an -8% fall for child-specific products and a -6% drop for adult products. Travel and driving has become common in local culture among adults and children these days, so fewer people are suffering from motion sickness when travelling.

SWITCHES

COMPETITIVE LANDSCAPE

  • Dong Wha Pharmaceutical Industrial Co Ltd retained the leading position in 2010 with 18% of value sales through its Gas Whalmyungsoo-Q brand, which accounted for 36% of digestive enzymes value sales in South Korea in 2010. The company released the new TV commercials with a campaign message instead of running public relations campaigns for products in 2010. The campaign focused on the fact that family members usually enjoy watching TV, but they do not talk with each other, with a message that recommended that all family members should get together to have breakfast or dinner at least once a day. Dong Wha Pharmaceutical Industrial Co Ltd stressed that Gas Whalmyungsoo-Q is a very long-standing brand, so the company launched the new TV commercials with a public interest message instead of showing information about the products so as to repay consumers for their loyalty.

PROSPECTS

  • Digestive remedies is expected to continue declining over the forecast period with a negative CAGR of 3% in constant value terms, with sales falling to less than Won144 billion by 2015. Furthermore, all categories in digestive remedies are expected to decline. South Koreans typically prefer to consult doctors when they suffer digestive discomfort, and the larger proportion of consumers is moving towards purchasing dietary supplements to help digestion instead of OTC products. This trend will further intensify in the future.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 42 Digestive Remedies Company Shares by Value 2006-2010
  • Table 43 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in South Korea - Category Analysis

TRENDS

  • OTC ear care products do not exist in South Korea. South Koreans tend to consult a doctor for ear, eye and throat problems, and OTC ear care products are not available in the country.

Eye Care in South Korea - Category Analysis

HEADLINES

CATEGORY DATA

  • Table 46 Sales of Eye Care by Category: Value 2005-2010
  • Table 47 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 48 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 49 Eye Care Company Shares by Value 2006-2010
  • Table 50 Eye Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 52 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in South Korea - Category Analysis

HEADLINES

TRENDS

  • Generally, South Korean consumers trust herbal/traditional ingredients due to their belief that they have fewer side-effects for the human body. However, preference for herbal/traditional ingredients varies depending on the particular category. In the OTC market, Western drugs still dominate, with the growth of herbal/traditional ingredients decreasing in analgesics and cold remedies in particular. On the other hand, the growth rate in digestive remedies increased by 3% with continuing popularity of traditional herbs based products.

COMPETITIVE LANDSCAPE

  • Korea Ginseng Corp maintained its leading position in South Korea’s herbal/traditional products with 34% value share in 2010. This is because of the company’s dominance in herbal/traditional dietary supplements where it held 38% value share. With the increasing popularity of red ginseng, the whole of herbal/traditional dietary supplements strongly increased. Due to the H1N1 outbreak and as people believed red ginseng helps to strengthen immunity, its sales soared, even during the economic downturn. As sales have grown, new players entered with diverse red ginseng brands, so that even if Korea Ginseng Corp’s value share declined, its actual value sales continued increasing.

PROSPECTS

  • Herbal/traditional products is expected to show positive growth over the forecast period with a 9% CAGR in constant value terms taking sales to Won2.8 trillion in 2015. More South Koreans will come to trust herbal/traditional ingredients as they have proved to be effective over a long period of time and cause few side-effects. However, growth is expected mainly in dietary supplements, where demand for herbal/traditional products is increasing to boost general health. Herbal/traditional dietary supplements is expected to post a 10% CAGR in constant value terms to reach Won2.6 trillion.

CATEGORY DATA

  • Table 53 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 54 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 55 Herbal/Traditional Products Company Shares 2006-2010
  • Table 56 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 57 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 58 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in South Korea - Category Analysis

HEADLINES

TRENDS

  • Hair loss treatments showed the strongest growth in 2010, rising 8% in current value terms to reach Won14 billion. It is well known that South Koreans are concerned about their appearance and hair loss is one of the most important issues, which not only men but also women are concerned about that these days. Manufacturers constantly concentrated on developing new products to minimise side-effects. There are new products appealing to female consumers in particular. As this issue becomes more important year-on-year, Rx treatment and simple surgery for hair loss treatment have increased much faster.

SWITCHES

COMPETITIVE LANDSCAPE

  • Topical germicidals/antiseptics are commonly purchased medicated skin care products in South Korea for use on small cuts and abrasions that can occur during daily life and this subcategory accounts for a quarter of total medicated skin care value sales in South Korea. Fucidin Oint by Dong Wha Pharmaceutical Industrial Co Ltd led topical germicidals/antiseptics with a 64% share of value sales in 2010, followed by Dong Kuk Pharm Co Ltd with a 35% share through its Madecassol Oint and Madecassol Powder brands in South Korea. These two companies have invested in active marketing activities to claim more share.

PROSPECTS

  • Medicated skin care is expected to continue posting negative growth over the forecast period with a CAGR of -1% in constant value terms to 2015 and sales falling to Won89 billion. Since the separation of medical and pharmaceutical services, the OTC market has suffered negative growth. There have been suggestions by the South Korean government and other related organisations about how to boost OTC healthcare sales, but little progress has been made. The negative growth is expected to continue during the forecast period.

CATEGORY DATA

  • Table 59 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 60 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 61 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 62 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 63 Acne Treatments Brand Shares by Value 2007-2010
  • Table 64 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in South Korea - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids can be divided into gum, lozenge, and patch formats. The patch format accounted for 55% of retail value and the gum format 44% in 2010. The lozenge format took only 1% and its sales were decreasing. In reality, the sales of patches are much higher than the gum format, but almost half the patches are purchased by the government to distribute complementarily to people who want to quit smoking.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson Korea Co Ltd maintained the leading position with a 55% value share with its Nicorette brand in 2010. Nicorette dominated in gum with a 95% share, and maintained second place in patches with 23%.

PROSPECTS

  • NRT smoking cessation aids is expected to record a modest constant value CAGR of less than 1% over the forecast period to reach Won11 billion by 2015 as the smoking population is declining in South Korea. Furthermore, South Korean consumers prefer to attempt to quit smoking without aids, even though the success rate without aids is known to be very low. However, as more regulations are put in place to encourage South Koreans to stop smoking, this group of consumers willing to quit smoking without aids will pose a threat to sales of NRT smoking cessation aids in the future.

CATEGORY DATA

  • Table 67 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 68 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 69 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 70 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 71 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 72 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 73 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 74 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in South Korea - Category Analysis

HEADLINES

CATEGORY DATA

  • Table 75 Sales of Sports Nutrition: Value 2005-2010
  • Table 76 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 77 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 78 Sports Nutrition Company Shares 2006-2010
  • Table 79 Sports Nutrition Brand Shares 2007-2010
  • Table 80 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 81 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Summary 22 Sports Nutrition, Category Rankings 2010

Vitamins and Dietary Supplements in South Korea - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements continued to see healthy growth in 2010 at 13% in current value terms. Herbal/Traditional dietary supplements showed an even stronger growth rate of 23% in 2010, on the other hand, non-herbal dietary supplements only recorded 3% growth in 2010. Vitamins and dietary supplements are very sensitive to trends, so the popularity of a particular category can fluctuate very easily. In recent years, red ginseng constantly showed a strong performance, with red ginseng becoming a much in-demand healthcare supplement for Koreans of all ages after the outbreak of H1N1.

COMPETITIVE LANDSCAPE

  • Korea Ginseng Corp maintained the leading position in 2010. Due to H1N1, the sales of red ginseng soared in 2009 because of the function that strengthens the immune system. At that time, various manufacturers entered red ginseng, now they produce not only ginseng dietary supplements, but also ginseng skin care products and confectionery. Koreans of all ages and sexes enjoyed red ginseng in diverse formats. The company also launched family gift sets and held promotional events for special days such as family month in May and Korean thanksgiving day. As it has looked to establish a corporate image for the whole family, from children to the oldest generations, the company has become close to consumers since gaining its independence after formerly being a government-owned organisation. Based on this reputation, Korea Ginseng Corp won The Company of Korea 2010 award in June for the fourth straight year.

PROSPECTS

  • Sales of vitamins and dietary supplements are expected to continue to increase by a CAGR 6% over the forecast period. Even if popular products are changed, the overall market area size will show positive growth due to Koreans’ increasing concerns about their health. Herbal/traditional dietary supplements will show a stronger growth rate than non-herbal/traditional dietary supplements, thanks to constant healthy growth in ginseng. Non-herbal/traditional dietary supplements will be replaced by new “individually approved” dietary supplements, so that overall sales will maintain their current size in the coming years.

CATEGORY DATA

  • Table 82 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 83 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 84 Dietary Supplements by Positioning 2005-2010
  • Table 85 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 86 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 87 Vitamins Brand Shares by Value 2007-2010
  • Table 88 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 89 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 90 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015
  • Summary 23 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in South Korea - Category Analysis

HEADLINES

TRENDS

  • Weight loss supplements continued to show positive growth of 32% in current value terms in 2010 to reach sales of Won495 billion. Garcinia cambogia (HCA) was newly popular, an extract from the garcinia cambogia fruit with the function to suppress switching of carbohydrate to fat. Koreans usually eat a lot of carbohydrate from rice, noodles, bread and rice cakes, so manufacturers explained that garcinia cambogia is suitable to the Korean body type and diet. Conjugated linoleic acid (CLA) also continued to enjoy popularity among female consumers and more manufacturers entered the market with new products in 2010.

COMPETITIVE LANDSCAPE

  • Direct selling companies like Herbalife Korea Co Ltd and Amway Korea Co Ltd operated weight management programmes consisting of their own slimming products. Amway Korea Co Ltd had a 3% value share with sales of Won16 billion in 2010. According to Amway Korea, weight management showed fluctuations depending on booms in certain popular products. The weight management programme of Herbalife Korea was quite famous among entertainers in South Korea. There was a consumers’ community internet site sharing information about Herbalife products and essays regarding weight management. The company also held the “Challenge! Herbal Diet” programme every year, in which participants received the right dietary life information and training to fix their wrong habits that were stopping them losing weight. With this marketing activity, the sales value of the company increased by 68% and it reached a 53% value share in 2010.

PROSPECTS

  • Weight management is expected to continue to show positive growth with a constant value CAGR of 7% over the forecast period taking sales to Won694 billion by 2015, mainly thanks to positive value growth of meal replacement slimming and weight loss supplements. With KFDA agreeing on the functionality of garcinia cambogia (HCA), new products containing HCA are expected to drive the market in the coming years.

CATEGORY DATA

  • Table 91 Sales of Weight Management: Value 2005-2010
  • Table 92 Sales of Weight Management: % Value Growth 2005-2010
  • Table 93 Weight Management Company Shares 2006-2010
  • Table 94 Weight Management Brand Shares 2007-2010
  • Table 95 Forecast Sales of Weight Management: Value 2010-2015
  • Table 96 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in South Korea - Category Analysis

HEADLINES

CATEGORY DATA

  • Table 97 Sales of Wound Care by Category: Value 2005-2010
  • Table 98 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 99 Wound Care Company Shares by Value 2006-2010
  • Table 100 Wound Care Brand Shares by Value 2007-2010
  • Table 101 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 102 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Isoflavones
            • Microalgae
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Chitosan
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report